---
schema_version: "secwatch.filing_event.v1"
accession: "0001932393-23-000124"
form_type: "8-K"
ticker: "GEHC"
cik: "0001932393"
company_name: "GE HealthCare Technologies Inc."
filed_at: "2023-10-31T23:59:59+00:00"
generated_at: "2026-06-09T05:01:59.564164+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# GE HealthCare Q3 revenue +6% organic; raises low end of adjusted EPS guidance

## Summary
- Revenue $4.8B, up 5% reported and 6% organic YoY; net income $375M vs $487M.
- Adjusted EPS $0.99 vs standalone adjusted $0.87 (+14%); GAAP EPS $0.83 vs $1.07.
- Adjusted EBIT margin 15.4% (+120 bps vs standalone 14.2%); free cash flow $570M (+$22M YoY).
- Full-year adjusted EPS raised to $3.75-$3.85 (prior $3.70-$3.85); organic growth 6%-8%.
- Imaging +5%, Ultrasound -1%, Patient Care Solutions +9%, Pharmaceutical Diagnostics +13%.

## SEC filing metadata
- accession: 0001932393-23-000124
- form_type: 8-K
- ticker: GEHC
- cik: 0001932393
- company_name: GE HealthCare Technologies Inc.
- filed_at: 2023-10-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1932393/000193239323000124/0001932393-23-000124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1932393/000193239323000124/gehc-20231031.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001932393-23-000124
- JSON: https://secwatch.observer/filing/0001932393-23-000124.json
- Plain text: https://secwatch.observer/filing/0001932393-23-000124.txt

## Key facts
- Earnings Releases
  GE HealthCare Technologies Inc. reported third quarter ended September 30, 2023 results: revenue $4.8 billion, net income $375 million, EPS $0.83. Guidance raised.
  - Period: third quarter ended September 30, 2023
  - Revenue: $4.8 billion
  - Net income: $375 million
  - EPS: $0.83
  - Guidance: raised
  - Result: reported results
  source text: management. We remain confident in our 2023 outlook as we continue to innovate for customers and patients.” Third Quarter 2023 Total Company Financial Performance • Revenues of $4.8 billion increased 5% reported and 6% on an Organic basis* year-over-year, driven by volume and price. • Total company book-to-bill, defined as Total orders divided by Total revenues, was
  evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000193239323000124/0001932393-23-000124-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.